Moreover, we combined LINC00839 expression data and TNM stage to establish a prognostic stratification model and stratified NPC patients into three risk groups: low-risk group (low LINC00839 expression and early TNM stage, n = 74), intermediate-risk group (high LINC00839 expression or advanced TNM stage, n = 92), and high-risk group (high LINC00839 expression and advanced TNM stage, n = 48). Here, LINC00839 is linked to nasopharyngeal carcinoma.